10 results match your criteria: "Guangxi Centers for Disease Control and Prevention[Affiliation]"
Disclosure experiences and challenges among adolescents living with HIV and their caregivers in China.
Int J Pediatr Adolesc Med
March 2018
Center for Global Health and Development, Boston University School of Public Health, Boston, MA, United States.
Background And Objectives: With increasing access to antiretroviral therapy, HIV-infected youth are living longer, but are vulnerable as they navigate the transition to adulthood while managing a highly stigmatized condition. Knowing one's HIV status is critical to assuming responsibility for one's health. The process of disclosure to adolescents living with HIV is not well understood globally, even less so in China.
View Article and Find Full Text PDFYellow fever outbreaks, vaccine shortages and the Hajj and Olympics: call for global vigilance.
Lancet
September 2016
Ministry of Health, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, PO Box 54146 Riyadh 11514, Saudi Arabia. Electronic address:
A crucial time for public health preparedness: Zika virus and the 2016 Olympics, Umrah, and Hajj.
Lancet
February 2016
Ministry of Health, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh 11514, Saudi Arabia. Electronic address:
Improving Adherence to Antiretroviral Therapy With Triggered Real-time Text Message Reminders: The China Adherence Through Technology Study.
J Acquir Immune Defic Syndr
August 2015
*Center for Global Health and Development, Boston University, Boston, MA; †Department of Global Health, Boston University School of Public Health, Boston, MA; ‡FHI 360, Beijing, China; §Research Center for Public Health (TPHRC), School of Medicine, Tsinghua University, Beijing, China; ‖WHO Collaborating Center for Comprehensive Management of HIV Treatment and Care, Ditan Hospital, Beijing, China; ¶AIDS Division, Guangxi Centers for Disease Control and Prevention, Nanning, China; #Center for Global Health, Massachusetts General Hospital, Boston, MA; **Department of Health Policy and Management, Boston University School of Public Health, Boston, MA; and ††Edith Nourse Rogers Memorial VA Hospital, Bedford, MA.
Background: Real-time adherence monitoring is now possible through medication storage devices equipped with cellular technology. We assessed the effect of triggered cell phone reminders and counseling using objective adherence data on antiretroviral therapy (ART) adherence among Chinese HIV-infected patients.
Methods: We provided ART patients in Nanning, China, with a medication device (Wisepill) to monitor their ART adherence electronically.
Introduction: Female sex workers (FSWs) are at highest risk for contracting HIV and facilitating the current heterosexual HIV epidemic in Guangxi, China, yet little is known of the impact of recent harm reduction campaigns in the province. We analyzed sentinel surveillance data collected between 2010 and 2012 in Guangxi to explore correlations between the prevalence of HIV, hepatitis C (HCV), and syphilis and risk behaviors of different categories of FSWs in Guangxi.
Methods: The sentinel surveillance data for 5,1790 FSWs in all 14 prefectures and 64 city/county regions of Guangxi, China from 2010 to 2012 were collected.
Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.
J Acquir Immune Defic Syndr
April 2015
*Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Treatment Research Institute, Philadelphia, PA; †Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; ‡Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD; §Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD and Department of Pathology, University of Minnesota, Minneapolis, MN; ‖State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China; ¶Department of Family Medicine, Faculty of Medicine, Chiang Mai University; #Guangxi Centers for Disease Control and Prevention, Guangxi Center for HIV/AIDS Prevention and Control, Nanning, China; **Xinjiang Autonomous Region Center for Disease Control and Prevention, Xinjiang, China; ††Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; ‡‡Department of Psychiatry, Yale School of Medicine, New Haven, CT; §§Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD; ‖‖Division of AIDS, Pharmaceutical Affairs Branch, National Institute of Allergy and Infectious Diseases; ¶¶Division of Intramural Research, National Institute of Allergy and Infectious Diseases; ##Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD; ***FHI 360; †††Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division; and ‡‡‡Division of AIDS, Prevention Sciences Branch, National Institute of Allergy and Infectious Diseases.
Background: Injection opioid use plays a significant role in the transmission of HIV infection in many communities and several regions of the world. Access to evidence-based treatments for opioid use disorders is extremely limited.
Methods: HIV Prevention Trials Network 058 (HPTN 058) was a randomized controlled trial designed to compare the impact of 2 medication-assisted treatment (MAT) strategies on HIV incidence or death among opioid-dependent people who inject drugs (PWID).
HIV prevalence, incidence and risk behaviours among men who have sex with men in Yangzhou and Guangzhou, China: a cohort study.
J Int AIDS Soc
March 2015
National Center for STD Control and Prevention, China Centers for Diseases Control and Prevention, Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing, China.
Introduction: In China, the prevalence and incidence of HIV among men who have sex with men (MSM) in large-sized cities have drawn much attention. In contrast, there has been a paucity of research focussing on the sexual health of MSM of medium-sized cities. This study fills this important gap in the knowledge by investigating the sexual health of MSM in a medium-sized city (Yangzhou) and a large-sized city (Guangzhou).
View Article and Find Full Text PDFHepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand.
Drug Alcohol Depend
September 2014
National Institute of Allergy and Infectious Diseases, Division of AIDS, Prevention Sciences Branch, 6700 B Rockledge Drive, Room 5121, Bethesda, MD 20892, United States.
Background: Buprenorphine/naloxone (BUP/NX), an effective treatment for opioid dependence, has been implicated in hepatic toxicity. However, as persons taking BUP/NX have multiple hepatic risk factors, comparative data are needed to quantify the risk of hepatoxicity with BUP/NX.
Methods: We compared rates of alanine aminotransferase (ALT) elevation≥grade 3 (ALT≥5.
Background: A prospective observational study of HIV seroincidence among high-risk injection drug users (IDU) was carried out in Guangxi, China. The primary objectives of this study were (1) to estimate HIV seroincidence (2) to estimate participant retention rate and (3) to evaluate changes in drug use and sexual behavior over a one year period.
Methods: Five hundred HIV seronegative IDU were enrolled.
HIV prevalence among injection drug users in rural Guangxi China.
Addiction
October 2006
Guangxi Centers for Disease Control and Prevention, Nanning, China.
Aims: To determine the HIV-1 seroprevalence, risk behaviors and demographic characteristics associated with HIV-1 infection among injection drug users (IDU) in rural Guangxi, China.
Design And Setting: Between July and November 2002, 702 IDU were screened for HIV-1 antibody through community outreach in rural Guangxi, China for enrollment in an HIV sero-incidence study.
Participants: A total of 702 active high-risk IDU were screened.